Sherveen Mashayekhi’s Post

Thrilled to witness the official launch of One2Treat! I'm eager to see how this innovative approach in clinical treatment assessment may transform the biopharma industry. Having seen its evolution during its incubation within IDDI over the past year, I can testify about One2Treat's dedication to patient-centricity. One2Treat’s digital solutions has the potential to bring broad impact on clinical trial designs, incorporating all key patient-relevant outcomes within a single primary analysis. This typically helps reduce the sample size by 20% and consequently the patient recruitment timelines. #Patientcentricity #Innovation #TrialDesign

We are so excited to share that Respiree and Whyze Health have joined Mayo Clinic Platform_Accelerate, our innovative accelerator program for health tech startups! Learn more about what these companies have already been working on and what they hope to accomplish throughout the 30-week program: Respiree™ is an AI/ML health tech company building state-of-the-art clinically-validated AI for managing disease progression across healthcare’s care continuum. The iRIS platform by Respiree™ uses data from the EHR and its proprietary US-patented and FDA-cleared sensor to longitudinal measure and track disease progression. Respiree™ is now available in US and Asia-Pacific and has signed commercial tie ups with global channel partners to scale up its offerings. Respiree™ is CE marked, has received regulatory clearances in Australia from the Therapeutic Goods Administration and has received the 510(k) clearance from the United States Food and Drug Administration (FDA). WHYZE Health Platform leverages AI to integrate clinical and patient data from both hospital and home environments. This comprehensive approach allows for the continuous monitoring of treatment efficacy, safety, and side effects. By utilizing AI-driven insights, the platform aids in making informed treatment choices, enhancing patient care and outcomes. Through its advanced data aggregation capabilities, WHYZE Health ensures a seamless and efficient healthcare experience, bridging the gap between clinical settings and home care. Want to follow their journey? Subscribe to the Accelerate monthly newsletter: https://lnkd.in/g96DtAtS #ai #healthcare #startups #healthtech #mayoclinicplatform

A big thank you to Saumitra Thakur from MedMountain Ventures for sharing his experiences as an MD turned venture capitalist with members of the Graduate Healthcare Club at Stanford University. Some takeaways: -Digital health start-ups that build for providers need to involve them early in the design process, as providers are resistant to changes in clinical workflows. -Derisk commercialization early; utilize existing reimbursement models if possible rather than creating novel ones, especially as an early stage start-up and when not well capitalized. -Regulatory trends in Generative AI will influence a new class of start-ups, similar to EHR adoption post-HITECH act. -The shift towards value-based care means that data fidelity, particularly for skilled nursing and other home health agencies with a huge documentation burden, will become increasingly important. -Medicare Advantage plans are fatigued by the proliferation of point solutions. How could future start-ups consolidate their offerings to make their solution more attractive? Thanks to Terry Lin and Phoebe Crosthwaite for Co-hosting this event.

🌟 Over the past year, we've witnessed a surge of groundbreaking innovation in the Digital Health sector. #GenerativeAI in Healthcare, the use of #LLM and #interoperability have been the three key words I had to listen to the most. To spotlight the #DigitalHealth development of the past 12 months, I created an ecosystem flashcard to highlight some of the new incumbents. 💰 These 50 ventures secured a total funding of $166.7 million at an average deal size of $6.9 million. Hippocratic AI secured the largest deal, raising $50 million. 🤝 Within their first year of existence, these ventures already secured 37 corporate and healthcare provider partnerships. Interestingly, the general focus hasn't changed much: - Most new ventures still focus on #HealthManagement, followed by Patient Solutions (e.g. DTx) - By therapeutic focus, #MentalHealth and Oncology remain high up, followed by Womens Health Create your own, see my comment 😁

🚼 Bloomlife Inc Connect is a comprehensive remote care platform that combines connected devices, such as Bloomlife’s fetal heart rate monitoring patch, with advanced data analytics (see Figure 2 below). 🩸 In addition to enabling patients to perform fetal nonstress tests outside of the high-cost clinical setting, the platform integrates other approved third-party devices including cellular-enabled blood pressure and blood glucose sensors to improve screening of hypertension and diabetes. 💰 With total funds raised now sitting at $20 million at the conclusion of a Series A, Bloomlife’s leading investors include RH Capital, Plug and Play Ventures, Marc Benioff, Noshaq, and HealthTech Capital. The company has also been granted $4.5 million from the National Science Foundation (NSF), the European Commission, and a Johnson & Johnson Quickfire Challenge, and it has earned nonfinancial awards from Fast Company as well as Frost & Sullivan. 👩 With the common goal of improving the standard of care in women’s health, MedTech Innovator cohort member Bloomlife has developed novel technologies with a human-centric approach. Here's how they did it: https://bit.ly/47EX1nu 📸 Image source: Bloomlife Inc #medtechinnovator #medicaldevices #medtech #womenshealth #womenshealthcare

🎉 Exciting News this week from Cacta ApS! 🎉 We're thrilled to announce that Cacta ApS has been selected to participate in Femovate by Guidea! We were selected from 130 startups across 6 continents because of our potential to positively impact women’s health and wellness in a critical area of femtech!   🚀 About the Sponsorship Femovate by Guidea provides expert UX research and design services for early stage femtech startups to give a small but powerful boost for companies like ours to shape the future of women’s health and wellness with well designed products and services.   🌟 Why It Matters Research from the World Economic Forum found that women-focused research could yield an economic return of over 40 times its investment. Femovate by Guidea’s support for Cacta ApS and the other selected startups has the potential to revolutionize access to healthcare globally–save lives, close health equity gaps, establish culturally sensitive care standards, and dramatically bolster the quality of life for women and people who are AFAB.   ❤️The support from Femovate by Guidea Programme truly fuels our mission to support the women affected by breast cancer-related treatment effects. We believe that early detection with home-monitoring device - MyLymphCare and timely treatment is the key to decrease chronic secondary lymphedema.   Thank you to Karin Dahlstrom and Theresa Neil and the Guidea team as well as Ida Tin and Erin Gallagher. We are eager to start working with you.   🏅 Learn More Read the Press Release Meet the startups selected for femovate 2023-24    #femtech #womenshealth #healthtech #digitalhealth #healthcare #healthcareinnovation #startups #innovation #health #medtech #healthcareresearch #femalehealth #genderhealthgap #funding #investment #healthequity

Six trends in healthcare that we saw at #hlth2023. What did you take away from the conference? 1. Medicaid takes center stage 2. The ‘startup ecosystem’ is back in a big way 3. Founders and funders should put their money where the TAM is 4. AI, trust top payers’ concerns 5. Content is healthcare’s newest market 6. Innovation abounds in Remote Patient Monitoring (RPM) despite market shutdown Read more in our newest blog post Redesign Health

I'm lucky to serve Prosper's HealthTech Accelerator Fall 2023 cohort as the entrepreneur-in-residence this fall. ICYMI: PHTA funds and accelerates uncommon teams who are reimagining healthcare. I need a little help finding 20-minute intro conversations with subject matter experts who: 1. Oversee the exchange and delivery of patient health records 2. Manage and/or organize clinical trails 3. Manage programs that focus on mental wellbeing for BIPOC youth populations

Despite a funding slowdown in Q3 2023 for digital health startups, the industry is showing resilience and focusing on key areas of growth. Disease treatment, nonclinical workflow solutions, and value-based care enablement are emerging as prime sectors for investment, reflecting a strategic shift. Public market performance remains stable, showcasing the sector's enduring potential. #DigitalHealth #HealthTech

Entrepreneurs and healthcare executives, take a look at this. "In 2023, digital health funding is shifting away from pandemic-era focuses of on-demand healthcare and life science R&D catalysts toward digital health products and services that support disease treatment, nonclinical workflow and management of complex conditions such as kidney disease." As investment shifts, it would be nice if there was a plug and play platform solution to make administering multiple disease specific programs easier from a customer perspective. The folks at Rock Health have done a nice job on this summary of digital health funding and market conditions.